The FDA May Approve MDMA to Treat PTSD: Here’s What to Know
An FDA advisory committee is set to review the use of MDMA-assisted therapy for the treatment of PTSD. This is a big deal.
Read More
Study: Intranasal Esketamine Is Just As Effective As IV Ketamine for Treating Depression
Is nasal ketamine (Spravato) as effective in treating depression than IV ketamine. This study appears to say yes.
Read More
Can Psychedelics Help Stutterers? A Study of Redditors Says Maybe
Can psychedelics help those who stutter? A study of Redditors says their may be hope, while more clinical research is needed.
Read More
An Overview of Psychedelic Clinical Trials and Drug Development Pipeline
The psychedelic clinical trials and drug development pipeline has been busy the last few decades. And the future is looking bright.
Read More
After Failure, California Legislative Psychedelics Advocates Hold Out Hope for 2026
Despite failing earlier this year, California's legislative psychedelic advocates are eyeing 2026 as the year to push through legalization.
Read More
This Nursing Association Updated Their Ketamine Therapy Guidelines
The AANA just updated their ketamine therapy guidelines. Here are the key takeaways that may have an impact on treatment.
Read More
Federal Health Agency Recognizes Psilocybin’s Therapeutic Potential For First Time
In a significant development, a federal health agency has acknowledged psilocybin's therapeutic potential.
Read More
Magic Mushrooms Offer Hope As A Potential Future Treatment for Anorexia Nervosa
Recent studies have begun to explore the potential of psilocybin in treating anorexia nervosa. The preliminary findings are promising.
Read More
VA Accelerates MDMA-Assisted Therapy for Veterans Amidst Escalating Suicide Crisis
The VA is fast-tracking the use of MDMA therapy for veterans with PTSD as FDA approval nears. But are they ready?
Read More
Study: Psychedelics Have A More Profound Effect on Older Adults
A recent study showed that psychedelics have a more profound impact on older adults than younger demographics.
Read More